Hamed Mirzaei

Dr. Hamed Mirzaei


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Ceramics International
Verified
Journal Article
Closed access
HMHamed Mirzaei
Hamed Mirzaei
MDMajid Darroudi
Majid Darroudi

1 January 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
HMHamed Mirzaei
Hamed Mirzaei
ASAbolfazl Shakeri
Abolfazl Shakeri
BRBahman Rashidi
Bahman Rashidi
AJAmin Jalili
Amin Jalili
ZBZarrin Banikazemi
Zarrin Banikazemi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

19 January 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SJSeyed Hamed Jafari
Seyed Hamed Jafari
ZSZahra Saadatpour
Zahra Saadatpour
ASArash Salmaninejad
Arash Salmaninejad
FMFatemeh Momeni
Fatemeh Momeni
MMMojgan Mokhtari
Mojgan Mokhtari
MKMojtaba Kianmehr
Mojtaba Kianmehr

1 January 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SRSomaye Rashki
Somaye Rashki
KAKasra Asgarpour
Kasra Asgarpour
HTHossein Tarrahimofrad
Hossein Tarrahimofrad
MHMaryam Hashemipour
Maryam Hashemipour
MEMohammad Saeid Ebrahimi
Mohammad Saeid Ebrahimi
HMHamed Mirzaei
Hamed Mirzaei

23 May 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ZHZahra Hoseini
Zahra Hoseini
FSFatemeh Sepahvand
Fatemeh Sepahvand
BRBahman Rashidi
Bahman Rashidi
ASAmirhossein Sahebkar
Amirhossein Sahebkar
AMAria Masoudifar
Aria Masoudifar
HMHamed Mirzaei
Hamed Mirzaei

10 March 2020 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
AVAsma Vafadar
Asma Vafadar
ZSZahra Shabaninejad
Zahra Shabaninejad
AMAhmad Movahedpour
Ahmad Movahedpour
FFFarzaneh Fallahi
Farzaneh Fallahi
MTMona Taghavipour
Mona Taghavipour
HMHamed Mirzaei
Hamed Mirzaei
Ovarian cancer is known as a serious malignancy that affects women’s reproductive tract and can considerably threat their health. A wide range of molecular mechanisms and genetic modifications have been involved in ovarian cancer pathogenesis making it difficult to develop effective therapeutic platforms. Hence, discovery and developing new therapeutic approaches are required. Medicinal plants, as a new source of drugs, could potentially be used alone or in combination with other medicines in the treatment of various cancers such as ovarian cancer. Among various natural compounds, quercetin has shown great anti-cancer and anti-inflammatory properties. In vitro and in vivo experiments have revealed that quercetin possesses a cytotoxic impact on ovarian cancer cells. Despite obtaining good results both in vitro and in vivo, few clinical studies have assessed the anti-cancer effects of quercetin particularly in the ovarian cancer. Therefore, it seems that further clinical studies may introduce quercetin as therapeutic agent alone or in combination with other chemotherapy drugs to the clinical setting. Here, we not only summarize the anti-cancer effects of quercetin but also highlight the therapeutic effects of quercetin in the ovarian cancer.